Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.03 BRL | +10.10% | +5.87% | +3.87% |
05-31 | European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower | MT |
05-29 | BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa | MT |
Sales 2024 * | 2.75B 2.99B 15.66B 234B | Sales 2025 * | 2.75B 2.99B 15.67B 235B | Capitalization | 22.39B 24.29B 127B 1,906B |
---|---|---|---|---|---|
Net income 2024 * | -435M -472M -2.48B -37.04B | Net income 2025 * | -572M -621M -3.26B -48.71B | EV / Sales 2024 * | 3.38 x |
Net cash position 2024 * | 13.08B 14.19B 74.43B 1,114B | Net cash position 2025 * | 12.47B 13.53B 70.96B 1,062B | EV / Sales 2025 * | 3.6 x |
P/E ratio 2024 * |
-51.4
x | P/E ratio 2025 * |
-41.5
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | +10.10% | ||
1 week | +5.87% | ||
1 month | +12.35% | ||
3 months | +19.16% | ||
6 months | +9.55% | ||
Current year | +3.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 01/06/08 |
Özlem Türeci
FOU | Founder | 57 | 01/06/08 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 30/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 31/12/21 |
Director/Board Member | 67 | 01/06/08 | |
Helmut Jeggle
CHM | Chairman | 53 | 01/06/08 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 33.03 | +10.10% | 4,745 |
29/05/24 | 30 | -0.70% | 17 |
28/05/24 | 30.21 | -2.71% | 1,551 |
27/05/24 | 31.05 | -0.48% | 1,931 |
Delayed Quote Sao Paulo, May 31, 2024 at 08:49 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B | |
+7.26% | 7.75B |
- Stock Market
- Equities
- BNTX Stock
- B1NT34 Stock